Breaking News Instant updates and real-time market news.

NEWR

New Relic

$63.18

-0.82 (-1.28%)

07:20
08/12/19
08/12
07:20
08/12/19
07:20

New Relic upgraded to Buy from Hold at Argus

  • 22

    Aug

  • 10

    Sep

  • 13

    Nov

NEWR New Relic
$63.18

-0.82 (-1.28%)

08/07/19
COWN
08/07/19
NO CHANGE
Target $100
COWN
Outperform
New Relic weakness a buying opportunity, says Cowen
Cowen analyst J. Derrick Wood cautioned investors prior to the New Relic Q2 result that the quarter could be rough and as predicted its billings were worse than expected and the September guidance was not enough causing the stock to move lower. He noted the shares are now selling at a large discount to peers while still growing in the mid-20%'s level with industry high gross margins and generating positive cash flow. Wood lowered his price target to $100 from $125 but maintained his Outperform rating on New Relic shares.
08/07/19
OPCO
08/07/19
NO CHANGE
Target $105
OPCO
Outperform
New Relic price target lowered to $105 from $125 at Oppenheimer
Oppenheimer analyst Ittai Kidron lowered his price target for New Relic to $105 from $125 after the company reported mixed Q1 results with sales/earnings ahead of expectations, but guidance highlighting execution and market challenges. The analyst reiterates an Outperform rating on the shares.
08/07/19
BMOC
08/07/19
NO CHANGE
Target $73
BMOC
Outperform
New Relic price target lowered to $73 from $115 at BMO Capital
BMO Capital analyst Keith Bachman lowered his price target on New Relic to $73 but kept his Outperform rating, saying that its Q1 billings missed leaves the stock "badly bruised" but not broken. The analyst notes that the company's sales cycle may have become elongated with a "confusing" new product suite, but remains positive on its "healthy" end markets and the reputation of its platform among the customers.
08/07/19
DADA
08/07/19
NO CHANGE
Target $95
DADA
Buy
New Relic price target lowered to $95 from $125 at DA Davidson
DA Davidson analyst Rishi Jaluria lowered his price target on New Relic to $95 after its "soft" Q1 results with a weak guidance and a miss in billings. The analyst notes that sales execution was challenged by the realigning GTM and product teams and growing competition from Datadog but believes that the selloff is overdone, keeping his Buy rating and recommending that investors take advantage of the pullback.

TODAY'S FREE FLY STORIES

ANAB

AnaptysBio

07:53
08/20/19
08/20
07:53
08/20/19
07:53
Recommendations
AnaptysBio analyst commentary  »

Cantor says AnaptysBio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOVA

Sunnova Energy

$11.13

0.089 (0.81%)

07:53
08/20/19
08/20
07:53
08/20/19
07:53
Initiation
Sunnova Energy initiated  »

Credit Suisse bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EL

Estee Lauder

$201.74

22.48 (12.54%)

07:50
08/20/19
08/20
07:50
08/20/19
07:50
Recommendations
Estee Lauder analyst commentary  »

Estee Lauder price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

IMMU

Immunomedics

$14.83

-0.11 (-0.74%)

07:49
08/20/19
08/20
07:49
08/20/19
07:49
Initiation
Immunomedics initiated  »

Cantor Fitzgerald starts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 09

    Sep

LVS

Las Vegas Sands

$54.67

2.28 (4.35%)

07:49
08/20/19
08/20
07:49
08/20/19
07:49
Downgrade
Las Vegas Sands rating change  »

Las Vegas Sands cut to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SILK

Silk Road Medical

$40.85

0.28 (0.69%)

07:44
08/20/19
08/20
07:44
08/20/19
07:44
Initiation
Silk Road Medical initiated  »

Silk Road Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

IQ

iQIYI

$18.10

1.02 (5.97%)

07:42
08/20/19
08/20
07:42
08/20/19
07:42
Downgrade
iQIYI rating change  »

iQIYI downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$120.16

-4.81 (-3.85%)

07:41
08/20/19
08/20
07:41
08/20/19
07:41
Recommendations
Sarepta analyst commentary  »

Sarepta price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNET

ChinaNet Online

$1.50

0.135 (9.89%)

07:41
08/20/19
08/20
07:41
08/20/19
07:41
Hot Stocks
ChinaNet CEO says will continue to integrate blockchain, AI tech into products »

CEO Handong Cheng,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EL

Estee Lauder

$201.74

22.48 (12.54%)

07:37
08/20/19
08/20
07:37
08/20/19
07:37
Recommendations
Estee Lauder analyst commentary  »

Estee Lauder price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

VVUS

VIVUS

$3.46

-0.02 (-0.57%)

07:36
08/20/19
08/20
07:36
08/20/19
07:36
Hot Stocks
VIVUS says study shows addition of Qsymia to LSG surgery improved weight loss »

VIVUS announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPLK

Splunk

$125.55

0.73 (0.58%)

07:36
08/20/19
08/20
07:36
08/20/19
07:36
Recommendations
Splunk analyst commentary  »

Splunk price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 28

    Aug

  • 15

    Oct

TPIC

TPI Composites

$17.49

-0.2 (-1.13%)

07:35
08/20/19
08/20
07:35
08/20/19
07:35
Upgrade
TPI Composites rating change  »

TPI Composites upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

PVTL

Pivotal Software

$13.85

-0.16 (-1.14%)

07:35
08/20/19
08/20
07:35
08/20/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

07:35
08/20/19
08/20
07:35
08/20/19
07:35
General news
Treasury Market Outlook: Treasuries are back in rally mode »

Treasury Market Outlook:…

DOW

Dow Inc.

$45.58

1.09 (2.45%)

07:34
08/20/19
08/20
07:34
08/20/19
07:34
Hot Stocks
Dow Inc. to retrofit Louisiana cracker with FCDh technology to produce propylene »

Dow announced it will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 24

    Oct

LULU

Lululemon

$178.63

0.83 (0.47%)

07:34
08/20/19
08/20
07:34
08/20/19
07:34
Recommendations
Lululemon analyst commentary  »

Lululemon earnings and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

EVER

EverQuote

$22.18

0.88 (4.13%)

07:34
08/20/19
08/20
07:34
08/20/19
07:34
Recommendations
EverQuote analyst commentary  »

EverQuote price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITRI

Itron

$70.02

0.3 (0.43%)

07:33
08/20/19
08/20
07:33
08/20/19
07:33
Downgrade
Itron rating change  »

Itron downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

BIIB

Biogen

$235.61

4.05 (1.75%)

, NVTA

Invitae

$25.78

0.6 (2.38%)

07:32
08/20/19
08/20
07:32
08/20/19
07:32
Hot Stocks
Biogen, Invitae announce availability of SMA STAT test »

Biogen (BIIB) and Invitae…

BIIB

Biogen

$235.61

4.05 (1.75%)

NVTA

Invitae

$25.78

0.6 (2.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

MBRX

Moleculin Biotech

$1.15

0.07 (6.48%)

07:32
08/20/19
08/20
07:32
08/20/19
07:32
Hot Stocks
Moleculin Biotech receives Emory University CTRC approval for WP1066 trial »

Moleculin Biotech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCOM

Qualcomm

$74.86

1.6 (2.18%)

07:31
08/20/19
08/20
07:31
08/20/19
07:31
Hot Stocks
Qualcomm, LGE enter new global patent license agreement »

Qualcomm announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 06

    Nov

CRM

Salesforce

$143.66

-0.23 (-0.16%)

07:31
08/20/19
08/20
07:31
08/20/19
07:31
Recommendations
Salesforce analyst commentary  »

Salesforce price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 28

    Aug

  • 28

    Aug

  • 12

    Dec

  • 16

    Dec

HAIN

Hain Celestial

$21.88

0.14 (0.64%)

07:28
08/20/19
08/20
07:28
08/20/19
07:28
Downgrade
Hain Celestial rating change  »

Hain Celestial downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 15

    Sep

VNO

Vornado

$61.34

0.14 (0.23%)

07:26
08/20/19
08/20
07:26
08/20/19
07:26
Downgrade
Vornado rating change  »

Vornado downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.